Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Zoetis Inc.
Zoetis, formerly Pfizer Inc.’s animal-medicine unit, surged nearly 20 percent on 66.8 million shares traded on its public-trading debut Friday. The Company’s more than 300 product lines include vaccines, parasiticides, anti-infectives, medicated feed additives and other pharmaceutical products.
Going forward ... (see research report)
Subscribe to News Feeds